Any L-alpha-amino acid carrying an N-acyl substituent.
ChEBI ID: 48927
| Member | Definition | Role |
|---|---|---|
| 4-aminobenzoylglutamic acid | A dipeptide resulting from the formal condensation of the carboxylic acid group of 4-aminobenzoic acid with the amino group of L-glutamic acid. | N-(4-aminobenzoyl)-L-glutamic acid |
| homocarnosine | A homocarnosine that has S configuration. | L-homocarnosine zwitterion; L-homocarnosine |
| sar 1118 | An N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). | lifitegrast |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 68 (28.69) | 18.7374 |
| 1990's | 51 (21.52) | 18.2507 |
| 2000's | 48 (20.25) | 29.6817 |
| 2010's | 45 (18.99) | 24.3611 |
| 2020's | 25 (10.55) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 19 (7.36%) | 5.53% |
| Reviews | 18 (6.98%) | 6.00% |
| Case Studies | 6 (2.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 215 (83.33%) | 84.16% |